Achmea Investment Management B.V. Bio Techne Corp Transaction History

Achmea Investment Management B.V.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$71.62 - $86.62 $595,448 - $720,158	-8,314 Reduced 94.67%	468 $35,000
Q4 2022 Feb 09, 2023	BUY	$80.67 - $352.29 $526,371 - $2.3 Million	6,525 Added 289.1%	8,782 $682,000
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $52,049 - $63,048	117 Added 5.47%	2,257 $1.09 Million
Q2 2021 Aug 06, 2021	BUY	$387.35 - $450.26 $828,929 - $963,556	2,140 New	2,140 $964,000

619

156M

161K

12.7K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.4B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

Stay updated on Achmea Investment Management B.V. with notifications on news.